Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

CEDIA Heroin Metabolite (6-AM) Assay

K-Number: K231007 · 2023-09-27

Decision Date2023-09-27
Product CodeDJG
Advisory CommitteeTX
DecisionSubstantially Equivalent

Device Summary

CEDIA Heroin Metabolite (6-AM) Assay is the device name listed in this FDA 510(k) record. The listed applicant is Microgenics Corporation. It received FDA 510(k) clearance on 2023-09-27 under 510(k) number K231007. The device is classified under product code DJG. It was reviewed by the TX advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the CEDIA Heroin Metabolite (6-AM) Assay?

CEDIA Heroin Metabolite (6-AM) Assay is a medical device that received FDA 510(k) clearance on 2023-09-27. The listed applicant is Microgenics Corporation. The 510(k) number is K231007.

When did CEDIA Heroin Metabolite (6-AM) Assay receive FDA 510(k) clearance?

CEDIA Heroin Metabolite (6-AM) Assay received FDA 510(k) clearance on 2023-09-27, under 510(k) number K231007.

Who is the listed applicant for CEDIA Heroin Metabolite (6-AM) Assay?

The FDA 510(k) record lists Microgenics Corporation as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for CEDIA Heroin Metabolite (6-AM) Assay?

The FDA product code for CEDIA Heroin Metabolite (6-AM) Assay is DJG.

Other records listing Microgenics Corporation as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

View all 13 devices →

Related Devices (Code: DJG)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.